These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 33300544)
21. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287 [TBL] [Abstract][Full Text] [Related]
22. Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Xiong Y; Neifert S; Karuppagounder SS; Liu Q; Stankowski JN; Lee BD; Ko HS; Lee Y; Grima JC; Mao X; Jiang H; Kang SU; Swing DA; Iacovitti L; Tessarollo L; Dawson TM; Dawson VL Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1635-1640. PubMed ID: 29386392 [TBL] [Abstract][Full Text] [Related]
23. Synaptic protein changes after a chronic period of sensorimotor perturbation in adult rats: a potential role of phosphorylation/O-GlcNAcylation interplay. Fourneau J; Canu MH; Cieniewski-Bernard C; Bastide B; Dupont E J Neurochem; 2018 Oct; 147(2):240-255. PubMed ID: 29808487 [TBL] [Abstract][Full Text] [Related]
24. The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD). Zhou ZD; Xie SP; Saw WT; Ho PGH; Wang H; Lei Z; Yi Z; Tan EK Cells; 2019 Aug; 8(8):. PubMed ID: 31426448 [No Abstract] [Full Text] [Related]
25. O-GlcNAcylation of truncated NAC segment alters peptide-dependent effects on α-synuclein aggregation. Ryan P; Xu MM; Davey AK; Kassiou M; Mellick GD; Rudrawar S Bioorg Chem; 2020 Jan; 94():103389. PubMed ID: 31753312 [TBL] [Abstract][Full Text] [Related]
26. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3 Suarez LM; Alberquilla S; García-Montes JR; Moratalla R J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281 [TBL] [Abstract][Full Text] [Related]
27. Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson's disease model. Stephano F; Nolte S; Hoffmann J; El-Kholy S; von Frieling J; Bruchhaus I; Fink C; Roeder T Sci Rep; 2018 Feb; 8(1):2372. PubMed ID: 29403026 [TBL] [Abstract][Full Text] [Related]
28. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells. Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421 [TBL] [Abstract][Full Text] [Related]
29. Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model. Lynch WB; Tschumi CW; Sharpe AL; Branch SY; Chen C; Ge G; Li S; Beckstead MJ Mov Disord; 2018 Dec; 33(12):1928-1937. PubMed ID: 30440089 [TBL] [Abstract][Full Text] [Related]
30. O-GlcNAcylation of α-Synuclein at Serine 87 Reduces Aggregation without Affecting Membrane Binding. Lewis YE; Galesic A; Levine PM; De Leon CA; Lamiri N; Brennan CK; Pratt MR ACS Chem Biol; 2017 Apr; 12(4):1020-1027. PubMed ID: 28195695 [TBL] [Abstract][Full Text] [Related]
31. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease. Duda J; Pötschke C; Liss B J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375 [TBL] [Abstract][Full Text] [Related]
32. Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson's Disease. Viereckel T; Dumas S; Smith-Anttila CJ; Vlcek B; Bimpisidis Z; Lagerström MC; Konradsson-Geuken Å; Wallén-Mackenzie Å Sci Rep; 2016 Oct; 6():35203. PubMed ID: 27762319 [TBL] [Abstract][Full Text] [Related]
36. Review: Parkinson's disease: from synaptic loss to connectome dysfunction. Bellucci A; Mercuri NB; Venneri A; Faustini G; Longhena F; Pizzi M; Missale C; Spano P Neuropathol Appl Neurobiol; 2016 Feb; 42(1):77-94. PubMed ID: 26613567 [TBL] [Abstract][Full Text] [Related]
37. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease. González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621 [TBL] [Abstract][Full Text] [Related]
38. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease. He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237 [TBL] [Abstract][Full Text] [Related]
39. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease. Sharma N; Rao SP; Kalivendi SV Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974 [TBL] [Abstract][Full Text] [Related]
40. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease. Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]